10/31/2024CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...

10/30/2024Zai Lab and BMS Move Toward KarXT Filing in China After Positive Phase...

10/30/2024Innovent Announces Positive Phase 2 Results for Picankibart in Psorias...

10/29/2024Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...

10/28/2024NiKang Presents Discovery of NKT3964, a FIC, Highly Potent and Selecti...

10/28/2024CSPC's BCMA-targeted mRNA-LNP-Based CAR-T SYS6020 Secures New Clinical...

10/28/2024CORXEL and LENZ Therapeutics Announce Positive Topline Data from China...

10/28/2024Beihai Biotech's BEIZRAY® (BH009) Receives FDA Approval for Multiple ...

10/28/2024Akeso's Gumokimab Shows Exceptional Long-Term Efficacy in Phase 3 Psor...

10/24/2024CASI Granted Chinese CTA Approval for CID-103 in Immune Thrombocytope...

10/22/2024Everest Announces Positive Results of Chinese Subpopulation Data from ...

10/21/2024Europe's Share of Global Clinical Trials Shrinks as China Gains Ground...

10/21/2024USFDA Grants Fast Track Designation to Coherent Biopharma's CBP-1008

10/21/2024CStone Announces Patent Publication for First-in-Class ADC CS5006

10/21/2024BeiGene's Secures 14th Indication in China for Tislelizumab

10/21/2024Akeso Launches Phase 1/2 Trial for Novel Bispecific Antibody Combinati...

10/18/2024AstraZeneca Submits Marketing Applications for Tremelimumab and Durval...

10/17/2024Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...

10/17/2024MSD Files NDA for WINREVAIR (sotatercept) in China

10/16/2024Hengrui Medicine Launches Phase 1/2 Trial for Nectin-4 ADC SHR-A2102 i...

10/16/2024Akeso Launches Phase 1/2 Trial of AK129 and AK117

10/16/2024GSK's Submits Priority Review Application for BCMA ADC in China

10/16/2024Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab

10/16/2024Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...

10/15/2024Dizal's Sunvozertinib Granted BTD in China for Treatment-Naive EGFR Ex...

10/15/2024BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...

10/10/2024Leads Biolabs Receives Breakthrough Therapy Designation in China for E...

10/10/2024InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...

10/8/2024CStone to Report Positive Preclinical Data of Anticancer Candidate CS2...

10/8/2024BeiGene Initiates Phase I Trial for FGFR2b ADC BG-C137 in Advanced Sol...

Page:17/18 Total number of articles:534: [First][<<] [14] [15] [16] [17] [18] [>>] [End]